ProjectPost-Market Registry to Evaluate the Safety and Efficacy of theSUPRAFLEX CRUZ™ Sirolimus eluting coronary stent…
Basic data
Title:
Post-Market Registry to Evaluate the Safety and Efficacy of theSUPRAFLEX CRUZ™ Sirolimus eluting coronary stent system in theTreatment of an Octo- and Nonagenarian All-Comer Patient Cohortwith Coronary Artery Disease
Duration:
08/12/2020 to 31/12/2024
Abstract / short description:
Prospective, multi-center, open-label, single-armed, non-interventional observational clinical investigation designed to enroll 2000 octo- and nonagenarian all-comer patients with coronary artery disease in up to 37 sites in Germany, Switzerland, and Austria. Patients underwent PCI using at least one Supraflex Cruz
Sirolimus Eluting stent as per current practice and will be followed up for 12 months.
Sirolimus Eluting stent as per current practice and will be followed up for 12 months.
Involved staff
Managers
Department of Internal Medicine
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Local organizational units
Internal Medicine Department III
Department of Internal Medicine
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Funders
Ludwigshafen am Rhein, Rheinland-Pfalz, Germany